
General Motors Co
GMNYSECIK 1467858Consumer discretionaryFiscal year ends Dec 31
Reports and events: 460 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2916:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-437768 |
| 2026-10-2706:30 ET | 8-K | 3.01 Delisting notice; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-432602 |
| 2026-10-2017:00 ET | 10-Q | Quarterly reportPeriod 2026-09-30 | 0001467858-26-000059 |
| 2026-10-2007:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-26-000056 |
| 2026-08-1116:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-344698 |
| 2026-07-2116:16 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001467858-26-000051 |
| 2026-07-2107:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-26-000049 |
| 2026-06-0416:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001467858-26-000044 |
| 2026-05-2616:15 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-26-239340 |
| 2026-04-2817:02 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001467858-26-000035 |
| 2026-04-2807:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-26-000033 |
| 2026-04-2016:35 ET | DEF 14A | Proxy statementPeriod 2025-12-31 | 0001467858-26-000022 |
| 2026-03-2316:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-119684 |
| 2026-01-2716:08 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001467858-26-000013 |
| 2026-01-2707:25 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-26-000011 |
| 2026-01-0816:02 ET | 8-K | 8.01 Other events | 0001467858-26-000005 |
| 2025-10-2116:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001467858-25-000143 |
| 2025-10-2107:38 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-25-000141 |
| 2025-10-1406:15 ET | 8-K | 2.06 Material impairments | 0001467858-25-000136 |
| 2025-07-2216:19 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001467858-25-000121 |
| 2025-07-2207:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-25-000119 |
| 2025-06-0516:08 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001467858-25-000112 |
| 2025-05-0716:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001193125-25-114935 |
| 2025-05-0116:13 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001467858-25-000096 |
| 2025-05-0106:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001467858-25-000093 |
| 2025-04-2907:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-25-000089 |
| 2025-04-2216:40 ET | DEF 14A | Proxy statementPeriod 2024-12-31 | 0001467858-25-000084 |
| 2025-03-2621:58 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-062882 |
| 2025-02-2606:31 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001467858-25-000063 |
| 2025-01-2815:40 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001467858-25-000032 |
| 2025-01-2807:24 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-25-000030 |
| 2024-12-1016:08 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-274336 |
| 2024-12-0406:31 ET | 8-K | 2.06 Material impairments | 0001193125-24-270298 |
| 2024-10-2216:02 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001467858-24-000117 |
| 2024-10-2207:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-24-000115 |
| 2024-10-0916:40 ET | 8-K/A | 5.02 Departure or appointment of officers or directors | 0001193125-24-235256 |
| 2024-10-0916:37 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001193125-24-235250 |
| 2024-09-0508:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-213712 |
| 2024-07-2315:23 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001467858-24-000102 |
| 2024-07-2307:13 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-24-000100 |
| 2024-06-2516:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-167894 |
| 2024-06-0617:02 ET | 8-K | 5.07 Shareholder vote results | 0001193125-24-156174 |
| 2024-04-2408:21 ET | DEF 14A | Proxy statementPeriod 2024-06-04 | 0001193125-24-108581 |
| 2024-04-2315:03 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001467858-24-000076 |
| 2024-04-2307:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-24-000074 |
| 2024-03-2816:12 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-080620 |
| 2024-01-3015:40 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001467858-24-000031 |
| 2024-01-3007:36 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001467858-24-000029 |
| 2023-12-1309:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-293982 |
| 2023-11-2909:15 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-284798 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.